EdgarLookup

EAST WEST BANCORP INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that EAST WEST BANCORP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
2395.7%
Profit Margin
Net income ÷ revenue
1.6%
Return on Assets
Net income ÷ assets
8.04x
Debt-to-Equity
Total liabilities ÷ equity
+4.4%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2019 Dec 31, 2019 $55.32M Feb 27, 2020
FY2019 Dec 31, 2018 $52.96M Feb 27, 2020
FY2019 Dec 31, 2017 $54.27M Feb 27, 2020
FY2018 Dec 31, 2016 $52.25M Feb 27, 2019

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.33B Feb 27, 2026
FY2025 Dec 31, 2024 $1.17B Feb 27, 2026
FY2025 Dec 31, 2023 $1.16B Feb 27, 2026
FY2024 Dec 31, 2022 $1.13B Feb 28, 2025
FY2023 Dec 31, 2021 $872.98M Feb 29, 2024
FY2022 Dec 31, 2020 $567.80M Feb 27, 2023
FY2019 Dec 31, 2019 $188.22M Feb 27, 2020
FY2019 Sep 30, 2019 $171.42M Feb 27, 2020
FY2019 Jun 30, 2019 $150.38M Feb 27, 2020
FY2019 Mar 31, 2019 $164.02M Feb 27, 2020

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.50B Feb 27, 2026
FY2025 Dec 31, 2024 $1.41B Feb 27, 2026
FY2025 Dec 31, 2023 $1.42B Feb 27, 2026
FY2024 Dec 31, 2022 $2.07B Feb 28, 2025
FY2023 Dec 31, 2021 $1.17B Feb 29, 2024
FY2022 Dec 31, 2020 $692.64M Feb 27, 2023
FY2021 Dec 31, 2019 $733.15M Feb 28, 2022
FY2020 Dec 31, 2018 $883.17M Feb 26, 2021
FY2019 Dec 31, 2017 $703.28M Feb 27, 2020
FY2018 Dec 31, 2016 $650.18M Feb 27, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2021 Dec 31, 2021 $6.02M Feb 28, 2022
FY2021 Dec 31, 2020 $2.66M Feb 28, 2022
FY2021 Dec 31, 2019 $9.86M Feb 28, 2022
FY2020 Dec 31, 2018 $13.79M Feb 26, 2021
FY2019 Dec 31, 2017 $13.75M Feb 27, 2020
FY2018 Dec 31, 2016 $12.18M Feb 27, 2019
FY2017 Dec 31, 2015 $6.56M Feb 27, 2018
FY2015 Dec 31, 2014 $11.85M Feb 26, 2016
FY2015 Dec 31, 2013 $88.11M Feb 26, 2016
FY2014 Dec 31, 2012 $10.28M Mar 2, 2015

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $80.43B Feb 27, 2026
FY2025 Dec 31, 2024 $75.98B Feb 27, 2026
FY2025 Dec 31, 2023 $69.61B Feb 27, 2026
FY2024 Dec 31, 2022 $64.11B Feb 28, 2025
FY2023 Dec 31, 2021 $60.87B Feb 29, 2024
FY2022 Dec 31, 2020 $52.16B Feb 27, 2023
FY2021 Dec 31, 2019 $44.20B Feb 28, 2022
FY2020 Dec 31, 2018 $41.04B Feb 26, 2021
FY2019 Dec 31, 2017 $37.12B Feb 27, 2020
FY2018 Dec 31, 2016 $34.79B Feb 27, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $71.54B Feb 27, 2026
FY2025 Dec 31, 2024 $68.25B Feb 27, 2026
FY2024 Dec 31, 2023 $62.66B Feb 28, 2025
FY2023 Dec 31, 2022 $58.13B Feb 29, 2024
FY2022 Dec 31, 2021 $55.03B Feb 27, 2023
FY2021 Dec 31, 2020 $46.89B Feb 28, 2022
FY2020 Dec 31, 2019 $39.18B Feb 26, 2021
FY2019 Dec 31, 2018 $36.62B Feb 27, 2020
FY2018 Dec 31, 2017 $33.28B Feb 27, 2019
FY2017 Dec 31, 2016 $31.36B Feb 27, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.90B Feb 27, 2026
FY2025 Dec 31, 2024 $7.72B Feb 27, 2026
FY2025 Dec 31, 2023 $6.95B Feb 27, 2026
FY2025 Dec 31, 2022 $5.98B Feb 27, 2026
FY2024 Dec 31, 2021 $5.84B Feb 28, 2025
FY2023 Dec 31, 2020 $5.27B Feb 29, 2024
FY2022 Dec 31, 2019 $5.02B Feb 27, 2023
FY2021 Dec 31, 2018 $4.42B Feb 28, 2022
FY2020 Dec 31, 2017 $3.84B Feb 26, 2021
FY2019 Dec 31, 2016 $3.43B Feb 27, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $465.70M Feb 27, 2026
FY2025 Dec 31, 2024 $465.70M Feb 27, 2026
FY2024 Dec 31, 2023 $465.70M Feb 28, 2025
FY2023 Dec 31, 2022 $465.70M Feb 29, 2024
FY2022 Dec 31, 2021 $465.70M Feb 27, 2023
FY2021 Dec 31, 2020 $465.70M Feb 28, 2022
FY2020 Dec 31, 2019 $465.70M Feb 26, 2021
FY2020 Dec 31, 2018 $465.55M Feb 26, 2021
FY2019 Dec 31, 2017 $469.43M Feb 27, 2020
FY2017 Dec 31, 2016 $469.43M Feb 27, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.30B Feb 27, 2026
FY2025 Dec 31, 2024 $7.31B Feb 27, 2026
FY2024 Dec 31, 2023 $6.47B Feb 28, 2025
FY2023 Dec 31, 2022 $5.58B Feb 29, 2024
FY2022 Dec 31, 2021 $4.68B Feb 27, 2023
FY2021 Dec 31, 2020 $4.00B Feb 28, 2022
FY2020 Dec 31, 2019 $3.69B Feb 26, 2021
FY2019 Dec 31, 2018 $3.16B Feb 27, 2020
FY2018 Dec 31, 2017 $2.58B Feb 27, 2019
FY2017 Dec 31, 2016 $2.19B Feb 27, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.19B Feb 27, 2026
FY2025 Dec 31, 2024 $5.25B Feb 27, 2026
FY2024 Dec 31, 2023 $4.61B Feb 28, 2025
FY2023 Dec 31, 2022 $3.48B Feb 29, 2024
FY2022 Dec 31, 2021 $3.91B Feb 27, 2023
FY2021 Dec 31, 2020 $4.02B Feb 28, 2022
FY2020 Dec 31, 2019 $3.26B Feb 26, 2021
FY2019 Dec 31, 2018 $3.00B Feb 27, 2020
FY2018 Dec 31, 2017 $2.17B Feb 27, 2019
FY2018 Dec 31, 2016 $1.88B Feb 27, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2019 Dec 31, 2018 $146.84M Feb 27, 2020
FY2018 Dec 31, 2017 $171.58M Feb 27, 2019
FY2017 Dec 31, 2016 $186.33M Feb 27, 2018
FY2016 Dec 31, 2015 $206.08M Feb 27, 2017
FY2015 Dec 31, 2014 $225.85M Feb 26, 2016
FY2014 Dec 31, 2013 $226.87M Mar 2, 2015
FY2013 Dec 31, 2012 $137.18M Mar 3, 2014
FY2012 Dec 31, 2011 $212.18M Feb 28, 2013
FY2011 Dec 31, 2010 $235.57M Feb 29, 2012

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 9 Feb 27, 2026
FY2025 Dec 31, 2024 8 Feb 27, 2026
FY2025 Dec 31, 2023 8 Feb 27, 2026
FY2024 Dec 31, 2022 7 Feb 28, 2025
FY2023 Dec 31, 2021 6 Feb 29, 2024
FY2022 Dec 31, 2020 3 Feb 27, 2023
FY2019 Dec 31, 2019 1 Feb 27, 2020
FY2019 Sep 30, 2019 1 Feb 27, 2020
FY2019 Jun 30, 2019 1 Feb 27, 2020
FY2019 Mar 31, 2019 1 Feb 27, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 9 Feb 27, 2026
FY2025 Dec 31, 2024 8 Feb 27, 2026
FY2025 Dec 31, 2023 8 Feb 27, 2026
FY2024 Dec 31, 2022 7 Feb 28, 2025
FY2023 Dec 31, 2021 6 Feb 29, 2024
FY2022 Dec 31, 2020 3 Feb 27, 2023
FY2019 Dec 31, 2019 1 Feb 27, 2020
FY2019 Sep 30, 2019 1 Feb 27, 2020
FY2019 Jun 30, 2019 1 Feb 27, 2020
FY2019 Mar 31, 2019 1 Feb 27, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2014 Dec 31, 2014 143.58M Mar 2, 2015
FY2014 Dec 31, 2013 137.63M Mar 2, 2015
FY2013 Dec 31, 2012 140.29M Mar 3, 2014
FY2012 Dec 31, 2011 149.33M Feb 28, 2013
FY2011 Dec 31, 2010 148.54M Feb 29, 2012